1. Home urine C-peptide creatinine ratio testing can identify type 2 and MODY in pediatric diabetes
- Author
-
Suzanne Hammersley, Beverley M. Shields, Andrew T. Hattersley, Rachel E J Besser, Timothy J. McDonald, Timothy Barrett, Zoe Gray, Kevin Colclough, and James Heywood
- Subjects
medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,Type 2 diabetes ,Gastroenterology ,Maturity onset diabetes of the young ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Interquartile range ,Internal medicine ,Diabetes mellitus ,Internal Medicine ,medicine ,Outpatient clinic ,030212 general & internal medicine ,Type 1 diabetes ,Creatinine ,business.industry ,medicine.disease ,3. Good health ,Postprandial ,Endocrinology ,chemistry ,Pediatrics, Perinatology and Child Health ,business - Abstract
Background Making the correct diabetes diagnosis in children is crucial for lifelong management. Type 2 diabetes and maturity onset diabetes of the young (MODY) are seen in the pediatric setting, and can be difficult to discriminate from type 1 diabetes. Postprandial urinary C-peptide creatinine ratio (UCPCR) is a non-invasive measure of endogenous insulin secretion that has not been tested as a diagnostic tool in children or in patients with diabetes duration
- Published
- 2012
- Full Text
- View/download PDF